Deanna Kline
Adult Health · Virginia Beach, VANPI 1841702107
Payments from drug & device makers
Across 148 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$345
- Novo Nordisk$275
- Lundbeck LLC$268
- AbbVie$210
- Amarin Pharma, Inc.$187
- Pfizer$179
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,68993%
- Education$1957%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 10 | $345 |
| Novo Nordisk | 17 | $275 |
| Lundbeck LLC | 11 | $268 |
| AbbVie | 12 | $210 |
| Amarin Pharma, Inc. | 9 | $187 |
| Pfizer | 10 | $179 |
| Amgen | 4 | $174 |
| GSK | 9 | $170 |
| Novartis | 9 | $141 |
| Lilly USA, LLC | 8 | $131 |
| AstraZeneca | 10 | $130 |
| Corium, LLC | 5 | $92 |
| Johnson & Johnson | 4 | $77 |
| Merck | 4 | $69 |
| Mylan Specialty L.p. | 5 | $68 |
| Amneal Pharmaceuticals LLC | 4 | $54 |
| Eisai Inc. | 2 | $46 |
| Irhythm Technologies, Inc. | 2 | $40 |
| Phadia US Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Acella Pharmaceuticals, LLC | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Abbott | 1 | $22 |
| Exact Sciences | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$130
How this compares
$2,884 in reported general payments places this provider in the 80th percentile of 368 adult health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 51 | $53,647 |
| OzempicSemaglutide | 23 | $26,003 |
| XareltoRivaroxaban | 12 | $16,447 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $13,725 |
| EntrestoSacubitril/Valsartan | 12 | $9,135 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $7,105 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $6,033 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 64 | $1,746 |
| Sertraline Hcl | 58 | $1,402 |
| Levothyroxine Sodium | 114 | $1,109 |
| Metoprolol Succinate | 96 | $1,100 |
| Atorvastatin Calcium | 116 | $922 |
| Nifedipine ErNifedipine | 18 | $808 |
| Losartan Potassium | 74 | $647 |
| Gabapentin | 58 | $643 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $179 | $53,64751 claims |
| Novo NordiskOzempic | $275 | $26,00323 claims |
| Johnson & JohnsonXarelto | $77 | $16,44712 claims |
| GSKTrelegy Ellipta | $170 | $13,72522 claims |
| NovartisEntresto | $141 | $9,13512 claims |
| MerckJanumet Xr | $69 | $7,10512 claims |
| AstraZenecaSymbicort | $130 | $6,03311 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $54 | $1,109114 claims |
| AbbVieSynthroid | $210 | $58819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 368 adult health providers in Virginia.
Other adult health in Virginia Beach
- Colleen DieringVirginia Beach$13K
- Patricia DuffVirginia Beach$4K
- Christine KesslerFort Belvoir$107K
- Denise BruenCharlottesville$45K
- Theresa Harrington StukusFairfax$40K
- Chelsea KoskovichFredericksburg$34K
- Brittany BrownLynchburg$14K
- Veronica HughesRichmond$12K
- Nicole SellersNorfolk$12K
- Amy WenzelMechanicsville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.